Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine

por Hyer, Randall N.
Publicado 2022

2287. Recently Approved HEPLISAV-B(R) [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Higher Proportion of Subjects Achieving Seroprotection With a More Consistent Immune R...

por Hyer, Randall N, Janssen, Robert
Publicado 2018

Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment”

por Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.
Publicado 2023

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape

por Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.
Publicado 2023

286. Hepatitis B Vaccine Compliance: Comparing 2-Dose and 3-Dose Vaccines

por Bruxvoort, Katia, Slezak, Jeff, Huang, Runxin, Sy, Lina S, Towner, William, Ackerson, Bradley, Reynolds, Kristi, Qian, Lei, Carlson, Cheryl M, Solano, Zendi, Hyer, Randall N, Janssen, Robert, Jacobsen, Steven J
Publicado 2019